CN105664255A - 一种天然组织来源的软骨联合骨脱细胞材料的制备方法 - Google Patents
一种天然组织来源的软骨联合骨脱细胞材料的制备方法 Download PDFInfo
- Publication number
- CN105664255A CN105664255A CN201610038724.4A CN201610038724A CN105664255A CN 105664255 A CN105664255 A CN 105664255A CN 201610038724 A CN201610038724 A CN 201610038724A CN 105664255 A CN105664255 A CN 105664255A
- Authority
- CN
- China
- Prior art keywords
- pbs
- cartilage
- bone
- associating
- synchondrosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 90
- 239000000463 material Substances 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims abstract description 21
- 210000001519 tissue Anatomy 0.000 title claims abstract description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 17
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims abstract description 15
- 239000000243 solution Substances 0.000 claims abstract description 14
- 239000007853 buffer solution Substances 0.000 claims abstract description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- 241000124008 Mammalia Species 0.000 claims abstract description 8
- 210000000845 cartilage Anatomy 0.000 claims description 97
- 238000002156 mixing Methods 0.000 claims description 24
- 230000000845 anti-microbial effect Effects 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 21
- 229930182555 Penicillin Natural products 0.000 claims description 19
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 19
- 229940049954 penicillin Drugs 0.000 claims description 19
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 claims description 19
- 230000002255 enzymatic effect Effects 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000011010 flushing procedure Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 239000007983 Tris buffer Substances 0.000 claims description 5
- 238000005238 degreasing Methods 0.000 claims description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 claims description 3
- 210000003041 ligament Anatomy 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 abstract description 17
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000005847 immunogenicity Effects 0.000 abstract description 2
- 239000008055 phosphate buffer solution Substances 0.000 abstract 4
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 229920002113 octoxynol Polymers 0.000 abstract 1
- 230000000399 orthopedic effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 230000007547 defect Effects 0.000 description 10
- 230000008439 repair process Effects 0.000 description 8
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 7
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 230000000890 antigenic effect Effects 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000004409 osteocyte Anatomy 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010010254 Concussion Diseases 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 201000010814 Synostosis Diseases 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 231100001083 no cytotoxicity Toxicity 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 201000009859 Osteochondrosis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000003848 cartilage regeneration Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003035 hyaline cartilage Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3612—Cartilage, synovial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610038724.4A CN105664255B (zh) | 2016-01-20 | 2016-01-20 | 一种天然组织来源的软骨联合骨脱细胞材料的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610038724.4A CN105664255B (zh) | 2016-01-20 | 2016-01-20 | 一种天然组织来源的软骨联合骨脱细胞材料的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105664255A true CN105664255A (zh) | 2016-06-15 |
CN105664255B CN105664255B (zh) | 2019-11-05 |
Family
ID=56302004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610038724.4A Active CN105664255B (zh) | 2016-01-20 | 2016-01-20 | 一种天然组织来源的软骨联合骨脱细胞材料的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105664255B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106943628A (zh) * | 2017-03-14 | 2017-07-14 | 浙江大学 | 一种天然组织来源的半月板脱细胞材料及其制备方法 |
CN107376022A (zh) * | 2017-06-27 | 2017-11-24 | 浙江大学 | 一种天然组织来源的卵巢脱细胞材料及其制备方法 |
CN107715177A (zh) * | 2016-07-26 | 2018-02-23 | 浙江大学 | 髓核细胞修饰猪小肠黏膜下层多重脱细胞材料的制备方法 |
CN108514657A (zh) * | 2018-04-04 | 2018-09-11 | 浙江大学 | 缓释igf-1生长因子的肌肉脱细胞材料的制备方法 |
CN108578774A (zh) * | 2018-04-04 | 2018-09-28 | 浙江大学 | 基于天然组织来源的脑组织脱细胞材料的制备方法 |
CN110227182A (zh) * | 2019-01-17 | 2019-09-13 | 浙江大学医学院附属邵逸夫医院 | 一种梯度矿化骨细胞外基质材料的制备方法 |
CN113425915A (zh) * | 2021-05-28 | 2021-09-24 | 宁波市第一医院 | 一种抗凝材料及其制备方法和应用 |
CN113577390A (zh) * | 2021-08-12 | 2021-11-02 | 红色未来科技(北京)有限公司 | 一种组织工程骨凝胶及其应用 |
CN113577391A (zh) * | 2021-08-20 | 2021-11-02 | 浙江大学医学院附属邵逸夫医院 | 一种天然组织来源的骺软骨联合骨脱细胞材料的制备方法 |
CN114796615A (zh) * | 2022-04-20 | 2022-07-29 | 诺一迈尔(苏州)医学科技有限公司 | 一种软骨脱细胞基质及其制备方法 |
CN115252902A (zh) * | 2022-08-08 | 2022-11-01 | 海南苏生生物科技有限公司 | 软骨细胞外基质的制备方法及其用到的脱细胞组合液和制得的软骨细胞外基质 |
WO2023040853A1 (zh) * | 2021-09-18 | 2023-03-23 | 浙江大学医学院附属邵逸夫医院 | 重建软组织-骨免疫修复环境骨膜-骨复合体及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110045566A1 (en) * | 2008-03-24 | 2011-02-24 | Zhichong Wang | method for preparing the decellularized matrix |
CN104307044A (zh) * | 2014-10-13 | 2015-01-28 | 浙江大学医学院附属邵逸夫医院 | 一种天然组织来源的全椎间盘脱细胞材料及其制备方法 |
CN104524634A (zh) * | 2014-12-17 | 2015-04-22 | 陕西佰傲再生医学有限公司 | 一种组织修复材料的制备方法 |
-
2016
- 2016-01-20 CN CN201610038724.4A patent/CN105664255B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110045566A1 (en) * | 2008-03-24 | 2011-02-24 | Zhichong Wang | method for preparing the decellularized matrix |
CN104307044A (zh) * | 2014-10-13 | 2015-01-28 | 浙江大学医学院附属邵逸夫医院 | 一种天然组织来源的全椎间盘脱细胞材料及其制备方法 |
CN104524634A (zh) * | 2014-12-17 | 2015-04-22 | 陕西佰傲再生医学有限公司 | 一种组织修复材料的制备方法 |
Non-Patent Citations (2)
Title |
---|
唐军民等: "《人体解剖学与组织胚胎学 第1版第1次印刷》", 28 February 2015, 北京:中央广播电视大学出版社 * |
杨强等: "新型脱细胞骨基质材料的制备及理化评估", 《中国组织工程研究与临床康复》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107715177B (zh) * | 2016-07-26 | 2020-11-13 | 浙江大学 | 髓核细胞修饰猪小肠黏膜下层多重脱细胞材料的制备方法 |
CN107715177A (zh) * | 2016-07-26 | 2018-02-23 | 浙江大学 | 髓核细胞修饰猪小肠黏膜下层多重脱细胞材料的制备方法 |
CN106943628A (zh) * | 2017-03-14 | 2017-07-14 | 浙江大学 | 一种天然组织来源的半月板脱细胞材料及其制备方法 |
CN107376022A (zh) * | 2017-06-27 | 2017-11-24 | 浙江大学 | 一种天然组织来源的卵巢脱细胞材料及其制备方法 |
CN108514657A (zh) * | 2018-04-04 | 2018-09-11 | 浙江大学 | 缓释igf-1生长因子的肌肉脱细胞材料的制备方法 |
CN108578774A (zh) * | 2018-04-04 | 2018-09-28 | 浙江大学 | 基于天然组织来源的脑组织脱细胞材料的制备方法 |
CN110227182A (zh) * | 2019-01-17 | 2019-09-13 | 浙江大学医学院附属邵逸夫医院 | 一种梯度矿化骨细胞外基质材料的制备方法 |
CN113425915A (zh) * | 2021-05-28 | 2021-09-24 | 宁波市第一医院 | 一种抗凝材料及其制备方法和应用 |
CN113577390A (zh) * | 2021-08-12 | 2021-11-02 | 红色未来科技(北京)有限公司 | 一种组织工程骨凝胶及其应用 |
CN113577391A (zh) * | 2021-08-20 | 2021-11-02 | 浙江大学医学院附属邵逸夫医院 | 一种天然组织来源的骺软骨联合骨脱细胞材料的制备方法 |
WO2023040853A1 (zh) * | 2021-09-18 | 2023-03-23 | 浙江大学医学院附属邵逸夫医院 | 重建软组织-骨免疫修复环境骨膜-骨复合体及制备方法 |
CN114796615A (zh) * | 2022-04-20 | 2022-07-29 | 诺一迈尔(苏州)医学科技有限公司 | 一种软骨脱细胞基质及其制备方法 |
CN114796615B (zh) * | 2022-04-20 | 2023-08-25 | 诺一迈尔(苏州)医学科技有限公司 | 一种软骨脱细胞基质及其制备方法 |
CN115252902A (zh) * | 2022-08-08 | 2022-11-01 | 海南苏生生物科技有限公司 | 软骨细胞外基质的制备方法及其用到的脱细胞组合液和制得的软骨细胞外基质 |
CN115252902B (zh) * | 2022-08-08 | 2023-12-19 | 海南苏生生物科技有限公司 | 软骨细胞外基质的制备方法及其用到的脱细胞组合液和制得的软骨细胞外基质 |
Also Published As
Publication number | Publication date |
---|---|
CN105664255B (zh) | 2019-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105664255A (zh) | 一种天然组织来源的软骨联合骨脱细胞材料的制备方法 | |
Jiang et al. | Clinical application status of articular cartilage regeneration techniques: tissue-engineered cartilage brings new hope | |
Parmaksiz et al. | Clinical applications of decellularized extracellular matrices for tissue engineering and regenerative medicine | |
Makris et al. | The knee meniscus: structure–function, pathophysiology, current repair techniques, and prospects for regeneration | |
Meng et al. | Animal models of osteochondral defect for testing biomaterials | |
CN105435307A (zh) | 天然组织来源的脱细胞联合脱钙骨材料及其制备方法 | |
Laurencin et al. | Tissue engineering: orthopedic applications | |
DE60208042T2 (de) | Zusammensetzung zur behandlung von schäden des gelenkknorpels | |
RU2451527C2 (ru) | Система in-situ для внутриартикулярной регенерации хрящевой и костной тканей | |
Scotti et al. | Healing of meniscal tissue by cellular fibrin glue: an in vivo study | |
Cissell et al. | Antigen removal for the production of biomechanically functional, xenogeneic tissue grafts | |
US20130304209A1 (en) | Biologic partial meniscus and method of preparation | |
Hettrich et al. | Cartilage repair: third-generation cell-based technologies—basic science, surgical techniques, clinical outcomes | |
CN104307045B (zh) | 一种天然组织来源的脱细胞骨膜材料的制备方法 | |
CN106075584B (zh) | 可注射性软骨脱细胞外基质混合脱钙骨基质水凝胶及其制备方法 | |
CN104307044B (zh) | 一种天然组织来源的全椎间盘脱细胞材料的制备方法 | |
CN105246495A (zh) | 来自非哺乳动物组织的脱细胞化的生物材料 | |
Tang et al. | Feasibility of Autologous Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Matrix Scaffold for Cartilage Tissue Engineering | |
Jiang et al. | Meniscus transplantation using treated xenogeneic meniscal tissue: viability and chondroprotection study in rabbits | |
Yang et al. | Bilayered scaffold with 3D printed stiff subchondral bony compartment to provide constant mechanical support for long-term cartilage regeneration | |
Schinhan et al. | Matrix-associated autologous chondrocyte transplantation in a compartmentalized early stage of osteoarthritis | |
Xuan et al. | A specific groove design for individualized healing in a canine partial sternal defect model by a polycaprolactone/hydroxyapatite scaffold coated with bone marrow stromal cells | |
CN101417151A (zh) | 生物源性含钙化层骨软骨组织工程支架 | |
CN106943628A (zh) | 一种天然组织来源的半月板脱细胞材料及其制备方法 | |
Liang et al. | Acellular matrix hydrogel for repair of the temporomandibular joint disc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160706 Address after: Jianggan District Qingchun Road Hangzhou city Zhejiang province 310016 No. 3 Applicant after: SIR RUN RUN SHAW HOSOITAL ZHEJIANG University SCHOOL OF MEDICINE Address before: Jianggan District Qingchun Road Hangzhou city Zhejiang province 310016 No. 3 Applicant before: Lin Xianfeng |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240313 Address after: Room B2-303-17, No. 198 Qidi Road, Economic and Technological Development Zone, Xiaoshan District, Hangzhou City, Zhejiang Province, 311202 Patentee after: Hangzhou Yuanbao Biotechnology Co.,Ltd. Country or region after: China Address before: Jianggan District Qingchun Road Hangzhou city Zhejiang province 310016 No. 3 Patentee before: SIR RUN RUN SHAW HOSOITAL ZHEJIANG University SCHOOL OF MEDICINE Country or region before: China |
|
TR01 | Transfer of patent right |